First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

National Institutes of Health

Federal funding opportunity PAR-25-180 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.